Carson Wealth (CWM LLC)’s Maravai LifeSciences MRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.28K Sell
1,866
-8
-0.4% -$27 ﹤0.01% 5004
2025
Q4
$6K Sell
1,874
-216
-10% -$727 ﹤0.01% 4759
2025
Q3
$6K Buy
2,090
+383
+22% +$978 ﹤0.01% 4687
2025
Q2
$4K Buy
1,707
+497
+41% +$1.04K ﹤0.01% 4695
2025
Q1
$3K Buy
1,210
+97
+9% +$383 ﹤0.01% 4651
2024
Q4
$6K Sell
1,113
-2,402
-68% -$15.5K ﹤0.01% 4131
2024
Q3
$29K Sell
3,515
-38
-1% -$328 ﹤0.01% 3120
2024
Q2
$25K Sell
3,553
-892
-20% -$7.7K ﹤0.01% 2973
2024
Q1
$39K Sell
4,445
-236,817
-98% -$1.6M ﹤0.01% 2463
2023
Q4
$1.58M Sell
241,262
-8,899
-4% -$57.5K 0.01% 635
2023
Q3
$2.5M Sell
250,161
-6,839
-3% -$75.1K 0.02% 499
2023
Q2
$3.19M Buy
257,000
+57,224
+29% +$772K 0.02% 434
2023
Q1
$2.8M Buy
199,776
+53,247
+36% +$765K 0.02% 430
2022
Q4
$2.1M Sell
146,529
-29,749
-17% -$468K 0.02% 439
2022
Q3
$4.5M Sell
176,278
-7,518
-4% -$189K 0.04% 298
2022
Q2
$5.22M Sell
183,796
-27,864
-13% -$883K 0.04% 287
2022
Q1
$7.46M Sell
211,660
-28,062
-12% -$941K 0.05% 247
2021
Q4
$10M Buy
+239,722
New +$9.71M 0.07% 209

Other funds holding MRVI

Carson Wealth (CWM LLC)'s MRVI Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its Maravai LifeSciences (MRVI) stake by 0.43% in Q1 2026, selling an estimated $27 and leaving 1,866 shares worth $5.28K. The position accounts for ﹤0.01% of the portfolio, ranked #5004.

Carson Wealth (CWM LLC) first reported a position in MRVI in Q4 2021 and has held it in 18 quarters since. The position peaked at $10M in Q4 2021. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • Carson Wealth (CWM LLC) held 1,866 shares of Maravai LifeSciences worth $5.28K as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 8 Maravai LifeSciences shares in Q1 2026, an estimated $27.
  • Maravai LifeSciences made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #5004 holding.
  • Carson Wealth (CWM LLC) first reported a position in Maravai LifeSciences in Q4 2021 and has held it in 18 quarters since.
  • Carson Wealth (CWM LLC)'s Maravai LifeSciences position peaked at $10M in Q4 2021.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.